Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank69
3Y CAGR-37.9%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
-37.9%/yr
Annual compound
Percentile
P69
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202432.37%
2023-702.05%
2022-62.83%
2021135.48%
20205230.59%
2019-5.29%
2018-148.94%
2017-98.58%
20162928.38%
2015-55.86%